This interview examines the principles of continuous improvement and how they can be applied to enhance QMS.
Brain Edema Risk May Be Lower With Modified Donanemab Dosing
An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still maintained sufficient amyloid reduction in